- Home
- DVA vs FUTU Comparison
DVA vs FUTU Comparison
Compare DVA & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DVA | FUTU |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 23.1B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DVA | FUTU |
|---|---|---|
| Price | $115.18 | $165.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $145.00 | ★ $208.60 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 10-29-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.63 | ★ 119.17 |
| EPS | ★ 9.76 | 8.95 |
| Revenue | ★ $13,317,965,000.00 | $2,442,834,991.00 |
| Revenue This Year | $6.50 | $87.24 |
| Revenue Next Year | $2.97 | $13.85 |
| P/E Ratio | ★ $11.80 | $18.41 |
| Revenue Growth | 5.14 | ★ 87.15 |
| 52 Week Low | $113.97 | $70.60 |
| 52 Week High | $179.60 | $202.53 |
Technical Indicators
Market Signals| Indicator | DVA | FUTU |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 44.54 |
| Support Level | $115.91 | $159.00 |
| Resistance Level | $122.40 | $166.67 |
| Average True Range (ATR) | 2.58 | 5.68 |
| MACD | -0.05 | -0.53 |
| Stochastic Oscillator | 6.02 | 34.79 |
Price Performance
Historical ComparisonAbout DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.